INOVIO Pharmaceuticals

INOVIO and Coherus BioSciences Join Forces for Phase 3 Clinical Trial in Throat Cancer Treatment

PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) has announced a clinical collaboration and supply agreement with Coherus BioSciences, Inc. (NASDAQ: CHRS) to evaluate the combination of INO-3112 and LOQTORZIâ„¢ (toripalimab-tpzi) …

INOVIO and Coherus BioSciences Join Forces for Phase 3 Clinical Trial in Throat Cancer Treatment Read More